Vaccination of patients with chronic myelogenous leukemia with bcr-abl oncogene breakpoint fusion peptides generates specific immune responses.
暂无分享,去创建一个
S. Soignet | D. Scheinberg | J. Kolitz | J. Pinilla-Ibarz | L. Lai | K. Cathcart | T. Korontsvit | M. Bocchia | J. Jimenez | J. Caggiano